Jun 28, 2026
15 MIN READ

Demystifying Wegovy Dosing: What’s the Lowest Dose and How It Paves the Path to Weight Loss

Starting with the lowest GLP-1 dose reduces side effects and builds tolerance, helping your body adapt gradually to weight loss medication. PlexusDx offers microdose protocols beginning at $129/month.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 28, 2026
15 MIN READ

demystifying wegovy dosing: what’s the lowest dose and how it paves the path to — PlexusDx GLP-1 education

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists like semaglutide have transformed weight management, but the right starting dose matters more than many patients realize. Clinical trials show that beginning with the lowest effective dose—typically 0.25 mg weekly for semaglutide—reduces nausea, vomiting, and gastrointestinal discomfort while maintaining significant weight loss outcomes. PlexusDx specializes in personalized dosing strategies that prioritize your comfort and long-term adherence from day one.

Understanding the Lowest GLP-1 Starting Doses

The lowest standard starting dose of semaglutide is 0.25 mg injected subcutaneously once weekly. This foundational dose allows your digestive system and appetite-control centers in the brain to adjust without overwhelming side effects. Most patients tolerate this entry-level dose well, experiencing appetite reduction and improved satiety cues within the first two weeks. Medical evidence supports starting low because it reduces the likelihood of treatment discontinuation due to tolerability concerns, meaning you're more likely to stay consistent with your medication plan.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, begins at an even lower 2.5 mg weekly injection. Because tirzepatide targets two hormone pathways simultaneously, starting at the minimum dose provides measurable metabolic benefits while giving your body time to adapt. This conservative approach doesn't compromise efficacy—clinical data demonstrates meaningful weight reduction even at the lowest tier, with dose escalation available as your tolerance improves over subsequent months.

Why Microdosing Protocols Support Weight Loss Success

Microdosing GLP-1 represents an intentional strategy to extend the adaptation window, sometimes using doses below FDA-approved minimums or distributing weekly doses across multiple smaller injections. This approach capitalizes on individual sensitivity to appetite suppression, allowing patients with lower baseline tolerance to achieve therapeutic benefit without excessive nausea or appetite loss that interferes with nutrition. The PlexusDx Microdose GLP-1 Protocol, starting at $129 monthly, is formulated through licensed 503A compounding pharmacies to provide flexible dosing that matches your body's unique response patterns.

Research suggests that patients who begin with microdose protocols experience better long-term compliance and fewer medication adjustments. When your starting dose aligns with your genetic predisposition to peptide sensitivity—something the PlexusDx Precision Peptide Genetic Test can identify by mapping variants in GLP1R, GIPR, FTO, and MC4R pathways—you're more likely to experience sustainable weight loss without the boom-and-bust cycle of side effects followed by dose avoidance.

How Your Dose Increases Without Price Increases

PlexusDx operates on a transparent pricing model where your monthly cost remains fixed even as your clinical dose adjusts upward. Starting at $149 monthly for compounded semaglutide injection or $129 for the Microdose GLP-1 Protocol, your price doesn't shift as your provider titrates your dose to your target level. This pricing structure removes the financial anxiety many patients feel when escalating medication, ensuring you can prioritize efficacy and tolerability without worrying about cost jumps at each dose tier.

Your dose may need to go up to reach your weight loss goals, but PlexusDx pricing stays the same across all commitment tiers. Whether you start at 0.25 mg semaglutide and progress to 1.0 mg, or begin microdose and advance to standard dosing, your monthly investment remains consistent, making it easier to plan your budget and focus on your health outcomes rather than escalating medication costs.

Personalization Through Genetic Testing and Clinical Monitoring

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) identifies how your DNA influences response to GLP-1 and GIP pathways. By analyzing 14 distinct metabolic and appetite-control pathways across 49 peptides, this test reveals whether you carry genetic variants associated with heightened medication sensitivity, faster metabolic adaptation, or greater appetite-suppression response. Patients with specific GIPR rs1800437 or GLP1R rs6923761 variants may benefit from extended microdosing phases, while those with FTO rs9939609 variants might require more aggressive titration to achieve target weight loss.

Combined with regular clinical assessment—weight tracking, side-effect review, and appetite-control goals—genetic insights allow PlexusDx providers to customize your dosing pathway before you experience problems. This proactive personalization means your lowest starting dose is truly the right dose for your biology, not just a generic industry standard. As your dose increases based on clinical response and genetic guidance, you stay on the most efficient trajectory toward your target weight with minimal adjustments.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the lowest dose of GLP-1 medication I can start with?

The lowest standard starting dose of semaglutide is 0.25 mg injected weekly, while tirzepatide begins at 2.5 mg weekly. PlexusDx also offers a Microdose GLP-1 Protocol at $129/month, which provides flexible, lower-dose formulations compounded through licensed 503A pharmacies for patients who need gentler initiation.

Will a low starting dose still help me lose weight?

Yes. Clinical trials demonstrate meaningful weight loss even at the lowest approved doses, with many patients experiencing 5–10% body weight reduction at baseline dosing alone. Starting low optimizes your tolerance and adherence, setting up long-term success without overwhelming side effects that could derail your treatment plan.

How much does the PlexusDx Microdose GLP-1 Protocol cost?

The PlexusDx Microdose GLP-1 Protocol starts at $129/month flat with no membership fees or insurance required. Your price remains fixed as your dose adjusts, and the medication is compounded by licensed 503A pharmacies, available in all 50 states and eligible for HSA/FSA.

What side effects should I expect at the lowest GLP-1 dose?

At the lowest starting doses, most patients experience mild nausea, reduced appetite, or slight fatigue that typically resolves within 3–5 days. These effects are generally milder at lower doses compared to higher tiers, which is why starting low and titrating gradually supports better overall tolerability and compliance.

Can genetic testing help me find my ideal starting dose?

Yes. The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes variants in GLP1R, GIPR, FTO, and MC4R that influence how your body responds to GLP-1 therapy. This insight helps your provider determine whether extended microdosing or standard titration best fits your genetic predisposition, personalizing your treatment from day one.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves